ORIGINAL RESEARCH
Accepted on 13 Feb 2025
Gut Microbiota-Derived Metabolite Phenylacetylglutamine Inhibits the Progression of Prostate Cancer by Suppressing the Wnt/β-Catenin Signaling Pathway
doi 10.3389/fphar.2025.1528058
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Novel Therapeutics for Urological Cancers
Novel Therapeutics for Urological Cancers
252
Total downloads
1,614
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 07 Feb 2025
Cepharanthine Hydrochloride: A Novel Ferroptosis-Inducing Agent for Prostate Cancer Treatment
doi 10.3389/fphar.2025.1536375
CASE REPORT
Published on 06 Feb 2025
Bladder-sparing therapy in a case report of huge muscle-invasive bladder IMT treated with 1470 nm diode laser en bloc resection followed by laparoscopic partial cystectomy
doi 10.3389/fonc.2025.1519676
- 155 views
ORIGINAL RESEARCH
Published on 09 Jan 2025
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
doi 10.3389/fphar.2024.1526051
- 478 views
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 1,614Topic views
- 717Article views
- 252Article downloads